Sleepiz launches contactless device for remote patient monitoring in the United States; appoints Robb LaChappelle as VP for the US
FDA listing paves the way for Sleepiz’ entry into the U.S. market and enables contactless, in-home respiration and heart rate measurement for remote patient monitoring and innovative medical study design.
10. September 2022
